Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACT: Microbiota Therapy for MDRO Colonization
NCT06321536Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Jan 2025
- Primary completion
- Jul 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Allogeneic Microbiota in Glycerol in multidrug resistant organism colonization (MDRO), sponsored by Emory University. Started Jan 2025; status: recruiting.
02
Drugs
Allogeneic Microbiota in Glycerol
03
Conditions
multidrug resistant organism colonization (MDRO)
Beyond the preview
Go deeper on NCT06321536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06321536.